Answers are grounded in this paper and cite their sources.
Targeted gene expression analysis reveals dysregulated pathways in preeclampsia, highlighting molecular insights.
Hypertensive disorders that manifest during pregnancy are leading causes of maternal and neonatal mortality worldwide. One such disorder, preeclampsia, has been linked to 2-8% of pregnancy-related complications. To better understand the molecular mechanisms underlying preeclampsia, a targeted gene expression analysis was conducted leveraging placental tissue samples from the Environmental Perinatal Outcome and Child Health (EPOCH) cohort. Total RNA was extracted and the expression of target genes, selected according to their plausible involvement in preeclampsia or related pathways, was analyzed using high-throughput PCR via the Fluidigm platform. After false discovery rate adjustment, adjustment for relevant covariates and completing batch effect correction, no significant differences in expression between preeclamptic and normotensive placentas or associations between any individual gene and increased odds of preeclampsia were observed. Nevertheless, key genes related to angiogenesis, immune response and cellular migration were observed to be dysregulated in preeclamptic placentas. This work underscores the variable nature of gene expression studies across unique cohorts and underlines the need for future work investigating the transcriptomic etiology of preeclampsia.
No takes yet. Share an insight, caveat, or question.
Christopher Wood (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: